➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Johnson and Johnson
Medtronic
Boehringer Ingelheim
Merck

Last Updated: October 31, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Exatecan

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Exatecan?

Exatecan is an investigational drug.

There have been 16 clinical trials for Exatecan. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2001.

The most common disease conditions in clinical trials are Sarcoma, Liver Neoplasms, and Pancreatic Neoplasms. The leading clinical trial sponsors are Daiichi Sankyo Inc., National Cancer Institute (NCI), and European Organisation for Research and Treatment of Cancer - EORTC.

Recent Clinical Trials for Exatecan
TitleSponsorPhase
Exatecan Mesylate in Treating Children With Relapsed or Refractory RhabdomyosarcomaDaiichi Sankyo Inc.Phase 2
Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell TumorDaiichi Sankyo Inc.Phase 2
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue SarcomaEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2

See all Exatecan clinical trials

Clinical Trial Summary for Exatecan

Top disease conditions for Exatecan
Top clinical trial sponsors for Exatecan

See all Exatecan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Johnson and Johnson
Medtronic
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.